Cognitive Impairment and cognitive fatigue during early cancer treatment in pediatric oncology depending on physical activity levels.

Publikation: Beitrag in Fachzeitschrift › Konferenz-Abstract in Fachzeitschrift › Forschung › Begutachtung

Originalsprache	Englisch
Zeitschrift	Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Jahrgang	2022
Ausgabenummer	30 (Suppl 1)
Publikationsstatus	Veröffentlicht - 01.07.2022

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

ChiMove - Chemobrain in Movement
Platschek, A. & Abeln, V.
01.01.16 → 31.10.20
Projekt: Hochschulinterne Forschungsförderung

@article{317bbbf0e33e484f8e5e07f6519ae33a,

title = "Cognitive Impairment and cognitive fatigue during early cancer treatment in pediatric oncology depending on physical activity levels.",

author = "Saskia Henckert and Thorsten Simon and Barbara Hero and Thomas Abel and Str{\"u}der, {Heiko Klaus} and Anna-Maria Platschek",

year = "2022",

month = jul,

day = "1",

language = "English",

volume = "2022",

journal = "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",

issn = "1433-7339",

publisher = "Springer Verlag",

number = "30 (Suppl 1)",

}

Publikation: Beitrag in Fachzeitschrift › Konferenz-Abstract in Fachzeitschrift › Forschung › Begutachtung

TY - JOUR

T1 - Cognitive Impairment and cognitive fatigue during early cancer treatment in pediatric oncology depending on physical activity levels.

AU - Henckert, Saskia

AU - Simon, Thorsten

AU - Hero, Barbara

AU - Abel, Thomas

AU - Strüder, Heiko Klaus

AU - Platschek, Anna-Maria

PY - 2022/7/1

Y1 - 2022/7/1

M3 - Conference abstract in journal

SN - 1433-7339

SN - 0941-4355

VL - 2022

JO - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

JF - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

IS - 30 (Suppl 1)

ER -